CNS Co (4076) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
22 Jul, 2026Executive summary
Revenue for Q1 FY2026 was ¥1,874 million, up 14.0% year-over-year, with operating profit at ¥182 million, up 128.7% year-over-year, and net profit at ¥154 million, up 181.6% year-over-year.
All business segments saw growth in both sales and gross profit, with notable contributions from new customer expansion and large-scale AI projects.
The company continues to execute its mid-term plan, aiming for ¥10 billion in sales and an operating margin above 10% by FY2030.
Financial highlights
Operating profit margin improved significantly, with operating profit up 128.7% and net profit up 181.6% year-over-year.
Gross profit for Technology Solutions rose 24.0%, Business Solutions 33.8%, and Consulting 35.6% year-over-year.
EPS for Q1 FY2026 was ¥53.27, compared to ¥18.92 in the prior year.
Total assets at quarter-end were ¥5,171 million, down ¥88 million from the previous year-end.
Outlook and guidance
Full-year guidance remains unchanged: revenue forecast at ¥8,253 million (+17.8% YoY), operating profit at ¥557 million (+0.3% YoY), and net profit at ¥427 million (flat YoY).
No revisions to previously announced forecasts; preparations for headquarters relocation are progressing as planned.
Latest events from CNS Co
- Double-digit revenue growth driven by DX and consulting, with profit growth to continue.4076
Q4 202422 Jul 2026 - Profit dropped sharply in Q1 FY2025 despite stable revenue, as labor costs surged.4076
Q1 202522 Jul 2026 - Revenue up 2.0% YoY, but profit down on higher costs; full-year outlook maintained.4076
Q2 202522 Jul 2026 - Revenue up 4.1% year-over-year, but profit margins declined on higher personnel costs.4076
Q3 202522 Jul 2026 - Revenue up 5.2% year-over-year, but profit margins declined amid higher costs and investments.4076
Q4 202522 Jul 2026 - Revenue and profits surged on robust DX/AI demand, prompting an upward revision to full-year guidance.4076
Q2 202622 Jul 2026 - Strong revenue and profit growth driven by DX/AI demand, with upwardly revised full-year outlook.4076
Q3 202622 Jul 2026 - Strong revenue and profit growth driven by DX/AI, with double-digit gains and robust FY2027 outlook.4076
Q4 202622 Jul 2026